SARS-CoV-2 inhibition and specific targeting of infected cells by VSV particles carrying the ACE2 receptor

Signal Transduct Target Ther. 2023 May 21;8(1):208. doi: 10.1038/s41392-023-01492-7.

Authors

Affiliations

¹ Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany. [email protected].
² Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
³ Institute of Pathology, Ulm University, Ulm, Germany.
⁴ Central Facility for Electron Microscopy, Ulm University, Ulm, Germany.
⁵ Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany. [email protected].

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Angiotensin-Converting Enzyme 2 / genetics
Antibodies, Neutralizing
COVID-19* / genetics
Humans
Peptidyl-Dipeptidase A / genetics
SARS-CoV-2*

Substances

Angiotensin-Converting Enzyme 2
Antibodies, Neutralizing
Peptidyl-Dipeptidase A